Management of ischemic heart disease in catheterization laboratories during the health contingency generated by the COVID-19 pandemic. Recommendations of the Mexican Interventional Cardiology Society (SOCIME)

Abstract

Abstract In Mexico, the number of confirmed and estimated cases of COVID-19 has been going up gradually from the second week of March 2020. This directly and indirectly altered the normal care of patients with ischemic heart disease. This is a consensus document achieved by different societies (the Mexican Society of Interventional Cardiology [SOCIME], the Mexican Society of Cardiology [SMC], the Mexican National Association of Cardiologists [ANCAM], the National Association of Cardiologists at the Service of State Workers [ANCISSSTE]), and the Coordinating Commission of National Institutes of Health and High Specialty Hospitals [CCINSHAE]). Its main objective is to guide the decision-making process on coronary revascularization procedures for the management of patients with acute coronary syndrome in catheterization laboratories during the current health emergency generated by the SARS-CoV-2 pandemic.

Keywords

• Myocardial infarction
• Acute coronary syndrome
• Percutaneous coronary intervention
• COVID-19
• SARS-CoV-2
• Pandemic